Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019-positive patients

Background: Although the SARS-CoV-2 Omicron variant is considered to induce less severe disease, there have been no consistent results on the extent of the decrease in severity. Objectives: To compare the clinical outcomes of COVID-19-positive patients with Omicron and Delta variant infection. Data sources: Searches were implemented up to 8 November 2022 in PubMed, Web of Science, BioRvix, and MedRvix. Study eligibility criteria: Eligible studies were cohort studies reporting the clinical outcomes of COVID-19 -positive patients with Omicron and Delta variant infection, including hospitalization, intensive care unit (ICU) admission, receiving invasive mechanical ventilation (IMV), and death. Participants: COVID-19-positive patients with Omicron and Delta variant infection. Assessment of risk of bias: Risk of bias was assessed employing the Newcastle-Ottawa Scale. Methods of data synthesis: Random-effect models were employed to pool the ORs and 95% CIs to compare the risk of clinical outcome. I2 was employed to evaluate the heterogeneity between studies. Results: A total of 33 studies with 6 037 144 COVID-19-positive patients were included in this metaanalysis. In the general population of COVID-19-positive patients, compared with Delta, Omicron variant infection resulted in a decreased risk of hospitalization (10.24% vs. 4.14%, OR = 2.91, 95% CI = 2.35 -3.60), ICU admission (3.67% vs. 0.48%, OR = 3.64, 95% CI = 2.63-5.04), receiving IMV (3.93% vs. 0.34%, OR = 3.11, 95% CI = 1.76-5.50), and death (2.40% vs. 0.46%, OR = 2.97, 95% CI = 2.17-4.08). In the hospitalized patients with COVID-19, compared with Delta, Omicron variant infection resulted in a decreased risk of ICU admission (20.70% vs. 12.90%, OR = 1.63, 95% CI = 1.32-2.02), receiving IMV (10.90% vs. 5.80%, OR = 1.65, 95% CI = 1.28-2.14), and death (10.72% vs. 7.10%, OR = 1.44, 95% CI = 1.22-1.71). Conclusions: Compared with Delta, the severity of Omicron variant infection decreased. Fei-Hong Hu, Clin Microbiol Infect 2023;29:835 & COPY; 2023 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Automated summary

This study compared the clinical outcomes of COVID-19-positive patients with Omicron and Delta variant infection. The results showed that compared with the Delta variant, the Omicron variant infection was associated with a decreased risk of hospitalization, ICU admission, receiving invasive mechanical ventilation, and death.